Impact of maternal circulating cholesterol and gestational diabetes mellitus on lipid metabolism in human term placenta

Molecular Reproduction and Development

Volumn 75, Issue 6, 2008, Pages 1054-1062

  Marseille Tremblay, Charles ^a   Ethier Chiasson, Maude ^a   Forest, Jean Claude ^b   Giguère, Yves ^b   Masse, André ^c   Mounier, Catherine ^a   Lafond, Julie ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Cholesterol; Fatty acid synthase; HMG CoA reductase; Human; Lipids; Placenta; SREBP

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; FATTY ACID SYNTHASE; INTERLEUKIN 1BETA; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; TUMOR NECROSIS FACTOR ALPHA; FASN PROTEIN, HUMAN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; MESSENGER RNA; SREBF1 PROTEIN, HUMAN; SREBF2 PROTEIN, HUMAN;

ADULT; ARTICLE; DIABETES MELLITUS; FEMALE; FETUS DEVELOPMENT; HUMAN; HYPERCHOLESTEROLEMIA; LIPID METABOLISM; LIPOGENESIS; MAJOR CLINICAL STUDY; MATERNAL BLOOD; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; BLOOD; CASE CONTROL STUDY; FETUS BLOOD; GENE EXPRESSION; GENETICS; METABOLISM; NEWBORN; PREGNANCY; PREGNANCY DIABETES MELLITUS; TERM BIRTH;

ADULT; CASE-CONTROL STUDIES; CHOLESTEROL; DIABETES, GESTATIONAL; FATTY ACID SYNTHETASE COMPLEX, TYPE I; FEMALE; FETAL BLOOD; GENE EXPRESSION; HUMANS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; INFANT, NEWBORN; LIPID METABOLISM; PLACENTA; PREGNANCY; RNA, MESSENGER; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; TERM BIRTH;

EID: 42949122028     PISSN: 1040452X     EISSN: 10982795     Source Type: Journal    
DOI: 10.1002/mrd.20842     Document Type: Article

References (53)

1. Archer DF, Mathur KS, Wiqvist N, Diczfalusy E. 1971. Quantitative assessment of the de novo sterol and steroid synthesis in the human foeto-placental unit. 2. Synthesis and secretion of steroids and steroid sulphates by the midgestation foetus. Acta Endocrinol (Copenh) 66:666-678.
2. Bansal N, Cruickshank JK, McElduff P, Durrington PN. 2005. Cord blood lipoproteins and prenatal influences. Curr Opin Lipidol 16:400-408.
3. Bligh EG, Dyer WJ. 1959. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911-917.
4. Cagen LM, Deng X, Wilcox HG, Park EA, Raghow R, Elam MB. 2004. Insulin activates the rat sterol regulatory element-binding protein 1c (srebp-1c) promoter through the combinatorial actions of srebp, lxr, sp-1, and nf-y cis-acting elements. Biochem J 385:207-216.
5. Chiang CT, Weng MS, Lin-Shiau SY, Kuo KL, Tsai YJ, Lin JK. 2005. Pu-erh tea supplementation suppresses fatty acid synthase expression in the rat liver through downregulating akt and jnk signalings as demonstrated in human hepatoma hepg2 cells. Oncol Res 16:119-128.
6. Datta S, Osborne TF. 2005. Activation domains from both monomers contribute to transcriptional stimulation by sterol regulatory element-binding protein dimers. J Biol Chem 280:3338-3345.
7. Deacon AC, Dawson PJ. 1979. Enzymic assay of total cholesterol involving chemical or enzymic hydrolysis - A comparison of methods. Clin Chem 25:976-984.
8. DeBose-Boyd RA, Ou J, Goldstein JL, Brown MS. 2001. Expression of sterol regulatory element-binding protein 1c (srebp-1c) mrna in rat hepatoma cells requires endogenous lxr ligands. Proc Natl Acad Sci USA 98:1477-1482.
9. Duricz P. 2003. Mechanisms of actions of statins and librates. Therapie 58:5-14.
10. Endo M, Masaki T, Seike M, Yoshimatsu H. 2007. Tnf-alpha induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protein-1c (srebp-1c). Exp Biol Med (Maywood) 232:614-621.
11. Ethier-Chiasson M, Duchesne A, Forest JC, Giguere Y, Masse A, Mounier C, Lafond J. 2007. Influence of maternal lipid profile on placental protein expression of ldlr and sr-bi. Biochem Biophys Res Commun 359:8-14.
12. Felder TK, Klein K, Patsch W, Oberkofler H. 2005. A novel srebp-1 splice variant: Tissue abundance and transactivation potency. Biochim Biophys Acta 1731:41-47.
13. Forsbach-Sanchez G, Tamez-Perez HE, Vazquez-Lara J. 2005. Diabetes and pregnancy. Arch Med Res 36:291-299.
14. Goldstein JL, Brown MS. 1990. Regulation of the mevalonate pathway. Nature 343:425-430.
15. Griffir MJ, Sul HS. 2004. Insulin regulation of fatty acid synthase gene transcription: Roles of usf and srebp-1c. IUBMB Life 56:595-600.
16. Grunfeld C, Verdier JA, Neese R, Moser AH, Feingold KR. 1988. Mechanisms by which tumor necrosis factor stimulates hepatic fatty acid synthesis in vivo. J Lipid Res 29:1327-1335.
17. Hanada T, Yoshimura A. 2002. Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev 13:413-421.
18. Heitritter SM, Solomon CG, Mitchell GF, Skali-Ounis N, Seely EW. 2005. Subclinical inflammation and vascular dysfunction in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab 90:3983-3988.
19. Hellig H, Gattereau D, Lefebvre Y, Bolte E. 1970. Steroid production from plasma cholesterol. I. Conversion of plasma cholesterol to placental progesterone in humans. J Clin Endocrinol Metab 30:624-631.
20. Herrera E, Amusquivar E, Lopez-Soldado I, Ortega H. 2006. Maternal lipid metabolism and placental lipid transfer. Horm Res 65:59-64.
21. Horton JD. 2002. Sterol regulatory element-binding proteins: Transcriptional activators of lipid synthesis. Biochem Soc Trans 30:1091-1095.
22. Horton JD, Goldstein JL, Brown MS. 2002a. Srebps: Activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109:1125-1131.
23. Horton JD, Goldstein JL, Brown MS. 2002b. Srebps: Transcriptional mediators of lipid homeostasis. Cold Spring Harb Symp Quant Biol 67:491-498.
24. Iddon CR, Wilkinson J, Bennett AJ, Bennett J, Salter AM, Higgins JA. 2001. A role for smooth endoplasmic reticulum membrane cholesterol ester in determining the intracellular location and regulation of sterol-regulatory- element-binding protein-2. Biochem J 358:415-422.
25. Janowski BA. 2002. The hypocholesterolemic agent ly295427 up-regulates insig-1, identifying the insig-1 protein as a mediator of cholesterol homeostasis through srebp. Proc Natl Acad Sci USA 99:12675-12680.
26. Jingami H, Brown MS, Goldstein JL, Anderson RG, Luskey KL. 1987. Partial deletion of membrane-bound domain of 3-hydroxy-3-methylglutaryl coenzyme a reductase eliminates sterol-enhanced degradation and prevents formation of crystalloid endoplasmic reticulum. J Cell Biol 104:1693-1704.
27. Kim C, Newton KM, Knopp RH. 2002. Gestational diabetes and the incidence of type 2 diabetes: A systematic review. Diabetes Care 25:1862-1868.
28. Lu S, Archer MC. 2007. Celecoxib decreases fatty acid synthase expression via down-regulation of c-jun n-terminal kinase-1. Exp Biol Med (Maywood) 232:643-653.
29. Magana MM, Koo SH, Towle HC, Osborne TF. 2000. Different sterol regulatory element-binding protein-1 isoforms utilize distinct co-regulatory factors to activate the promoter for fatty acid synthase. J Biol Chem 275:4726-4733.
30. Mathur RS, Archer DF, Wiqvist N, Diczfalusy E. 1970. Quantitiative assessment of the de novo sterol and steroid synthesis in the human foeto-placental unit. I. Synthesis and secretion of cholesterol and cholesterol sulphate. Acta Endocrinol (Copenh) 65:663-674.
31. Mondestin MA, Ananth CV, Smulian JC, Vintzileos AM. 2002. Birth weight and fetal death in the united states: The effect of maternal diabetes during pregnancy. Am J Obstet Gynecol 187:922-926.
32. Mounier C, Posner BI. 2006. Transcriptional regulation by insulin: From the receptor to the gene. Can J Physiol Pharmacol 84:713-724.
33. Palinski W, D'Armiento FP, Witztum JL, de Nigris F, Casanada F, Condorelli M, Silvestre M, Napoli C. 2001. Maternal hypercholesterolemia and treatment during pregnancy influence the long-term progression of atherosclerosis in offspring of rabbits. Circ Res 89:991-996.
34. Pizer ES, Kurman RJ, Pasternack GR, Kuhajda FP. 1997. Expression of fatty acid synthase is closely linked to proliferation and stromal decidualization in cycling endometrium. Int J Gynecol Pathol 16:45-51.
35. Repa JJ, Liang G, Ou J, Bashmakov Y, Lobaccaro JM, Shimomura I, Shan B, Brown MS, Goldstein JL, Mangelsdorf DJ. 2000. Regulation of mouse sterol regulatory element-binding protein-1c gene (srebp-1c) by oxysterol receptors, lxralpha and lxrbeta. Genes Dev 14:2819-2830.
36. Ruan XZ, Moorhead JF, Fernando R, Wheeler DC, Powis SH, Varghese Z. 2004. Regulation of lipoprotein trafficking in the kidney: Role of inllammalory mediators and transcription factors. Biochem Soc Trans 32:88-91.
37. Ruan XZ, Moorhead JF, Tao JL, Ma KL, Wheeler DC, Powis SH, Varghese Z. 2006. Mechanisms of dysregulation of low-density lipoprotein receptor expression in vascular smooth muscle cells by inflammatory cytokines. Arterioscler Thromb Vasc Biol 26:1150-1155.
38. Saklatvala J, Dean J, Clark A. 2003. Control of the expression of inflammatory response genes. Biochem Soc Symp 70:95-106.
39. Salles J, Sargueil F, Knoll-Gellida A, Witters LA, Shy M, Jiang H, Cassagne C, Garbay B. 2002. Fatty acid synthase expression during peripheral nervous system myelination. Brain Res Mol Brain Res 101:52-58.
40. Sever N, Yang T, Brown MS, Goldstein JL, DeBose-Boyd RA. 2003. Accelerated degradation of hmg coa reductase mediated by binding of insig-1 to its sterol-sensing domain. Mol Cell 11:25-33.
41. Shaat N, Groop L. 2007. Genetics of gestational diabetes mellitus. Curr Med Chem 14:569-583.
42. Shi W, Swan KF, Lear SR, O'Neil JS, Erickson SK, Henson MC. 1999. Regulation of pathways determining cholesterol availability in the baboon placenta with advancing gestation. Biol Reprod 61:1499-1505.
43. Shimano H. 2001. Sterol regulatory element-binding proteins (srebps): Transcriptional regulators of lipid synthetic genes. Prog Lipid Res 40:439-452.
44. Shimomura I, Shimano H, Horton JD, Goldstein JL, Brown MS. 1997. Differential expression of exons 1a and 1c in mrnas for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells. J Clin Invest 99:838-845.
45. Tamura Y, Kawamori R. 2006. Insulin resistance. Nippon Rinsho 64:1071-1074.
46. Urban G, Marinoni E, Di Iorio R, Lucchini C, Alo P, Di Tondo U. 2001. New placental factors: Between implantation and inflammatory reaction. Early Pregnancy 5:70-71.
47. Valverde AM, Benito M, Lorenzo M. 2005. The brown adipose cell: A model for understanding the molecular mechanisms of insulin resistance. Acta Physiol Scand 183:59-73.
48. Wakil SJ, Stoops JK, Joshi VC. 1983. Fatty acid synthesis and its regulation. Annu Rev Biochem 52:537-579.
49. Wilentz RE, Witters LA, Pizer ES. 2000. Lipogenic enzymes fatty acid synthase and acetyl-coenzyme a carboxylase are coexpressed with sterol regulatory element binding protein and ki-67 in fetal tissues. Pediatr Dev Pathol 3:525-531.
50. Woollett LA. 2005. Maternal cholesterol in fetal development: Transport of cholesterol from the maternal to the fetal circulation. Am J Clin Nutr 82:1155-1161.
51. Xu J, Teran-Garcia M, Park JH, Nakamura MT, Clarke SD. 2001. Polyunsaturated fatty acids suppress hepatic sterol regulatory element-binding protein-1 expression by accelerating transcript decay. J Biol Chem 276:9800-9807.
52. Yabe D, Komuro R, Liang G, Goldstein JL, Brown MS. 2003. Liver-specific mrna for insig-2 down-regulated by insulin: Implications for fatty acid synthesis. Proc Natl Acad Sci USA 100:3155-3160
53. Yang YA, Han WF, Morin PJ, Chrest FJ, Pizer ES. 2002. Activation of fatty acid synthesis during neoplastic transformation: Role of mitogen-activated protein kinase and phosphatidylinositol 3-kinase. Exp Cell Res 279:80-90.